EcoDrugPlus


Display Options: Drug type Therapeutic Area Route of Adminstration Mechanism of Action Indication Status


Small molecule Approved Unknown Unknown Essential Hypertension; Hypertension; Cardiovascular Diseases Unknown


Small molecule Approved CARDIOVASCULAR; OTHER ORAL Hypertension; Stroke Type-1 angiotensin II receptor antagonist


Small molecule Approved EYE OPHTHALMIC Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension Prostanoid FP receptor agonist


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY INTRAMUSCULAR; ORAL Carcinoma, Renal Cell; Coronary Disease; Prostatic Neoplasms, Castration-Resistant; Sexual Dysfunction, Physiological; Spinal Cord Injuries; Aging; Malnutrition; Respiratory Insufficiency; Hypogonadism; Klinefelter Syndrome; Neoplasms; Orchitis Androgen Receptor agonist


Small molecule Approved Unknown INTRAMUSCULAR Psychotic Disorders; Autistic Disorder; Bipolar Disorder; Depressive Disorder, Major; Schizophrenia; Tourette Syndrome Dopamine D2 receptor partial agonist


Small molecule Approved Unknown ORAL HIV Infections; Hepatitis B, Chronic Human immunodeficiency virus type 1 reverse transcriptase inhibitor


Small molecule Approved Unknown Unknown Amyotrophic Lateral Sclerosis; Insulin Resistance; Hepatitis D; Leukemia, Lymphocytic, Chronic, B-Cell; Acquired Immunodeficiency Syndrome; HIV Infections; Hepatitis B, Chronic; Severe Acute Respiratory Syndrome; Virus Diseases Human immunodeficiency virus type 1 reverse transcriptase inhibitor


Small molecule Approved Unknown Unknown Liver Diseases; Biliary Tract Neoplasms; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Carcinoid Heart Disease Tryptophan 5-hydroxylase inhibitor


Small molecule Approved Unknown ORAL Kidney Diseases; Liver Diseases; Aspergillosis, Allergic Bronchopulmonary; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophies; Muscular Dystrophy, Duchenne Glucocorticoid receptor agonist


Small molecule Approved Unknown ORAL Influenza, Human; Virus Diseases Polymerase acidic protein inhibitor


Small molecule Approved Unknown Unknown Hematologic Neoplasms; Lymphoma; Ovarian Neoplasms; Pneumonia; Anemia, Hemolytic, Autoimmune; Glomerulonephritis, IGA; Hidradenitis Suppurativa; Lymphoma, Large B-Cell, Diffuse; Primary Myelofibrosis; Severe Acute Respiratory Syndrome; Arthritis, Rheumatoid; Purpura, Thrombocytopenic, Idiopathic; Hemorrhage Tyrosine-protein kinase SYK inhibitor


Small molecule Approved Unknown Unknown Unknown Unknown


Small molecule Approved Unknown Unknown Pneumonia, Viral; Hemorrhagic Fever, Ebola; Respiratory Distress Syndrome; Severe Acute Respiratory Syndrome; Virus Diseases RNA-directed RNA polymerase L inhibitor


Small molecule Approved Unknown Unknown Breast Neoplasms; Carcinoma, Hepatocellular; Friedreich Ataxia; Neoplasms; Colorectal Neoplasms; Conjunctivitis, Allergic; Crohn Disease; Cytomegalovirus Infections; Fever; Malaria, Falciparum; Malaria, Vivax; Schistosomiasis; Schistosomiasis haematobia; Severe Acute Respiratory Syndrome; Malaria Unknown


Small molecule Investigational Unknown Unknown Fever; Marburg Virus Disease; Severe Acute Respiratory Syndrome Genome polyprotein inhibitor


Small molecule Investigational Unknown Unknown Lymphoma; Neoplasms Unknown


Small molecule Investigational Unknown Unknown Hypercholesterolemia; Hyperlipidemias; Non-alcoholic Fatty Liver Disease Thyroid hormone receptor beta-1 agonist


Small molecule Investigational Unknown Unknown Neuralgia; Depressive Disorder; Depressive Disorder, Major; Hypertension, Pulmonary Glutamate [NMDA] receptor antagonist


Small molecule Investigational Unknown Unknown Infections Bacterial 70S ribosome inhibitor


Small molecule Approved Unknown Unknown Severe Acute Respiratory Syndrome; Schizophrenia; Malaria Unknown

1
2
3
4
Next »


Download Option

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).